Dr. Robin Dale Hanson, MD is a pediatric oncologist in St. Louis, MO specializing in pediatric oncology. He graduated from Washington University in St. Louis School of Medicine. Dr. Robin Dale Hanson, MD is affiliated with Mercy Hospital South, Mercy Health System, Mercy Hospital St. Louis and Mercy Kids, Adolescents and Young Adults Infusion Center - St. Louis.
Dr. Robin Dale Hanson, MD graduated from Washington University in St. Louis School of Medicine. He completed residency at St. Louis Children's Hospital. He is certified by the Board Certification: Amer Bd Pediatrics (Pediatric Hematology/Oncology) and has a state license in Missouri.
Medical School: Washington University in St. Louis School of Medicine
Residency: St. Louis Children's Hospital
Board Certification: Board Certification: Amer Bd Pediatrics (Pediatric Hematology/Oncology)
Licensed In: Missouri
Dr. Robin Dale Hanson, MD appears to accept the following insurance providers: WellCare Medicare Advantage, Aetna, United Healthcare, Humana, Cigna, Anthem BlueCross BlueShield, HealthLink, Health Net Federal Services, HFN, Inc., MultiPlan/PHCS, Home State Health, Medica, Healthy Blue (formerly Missouri Care), NHC Advantage, Live360 (Health Choices Network), Sterling Medicare, Essence, PPHP (Provider Partners Health Plan) and Ascension Smart Health.
According to our sources, Dr. Robin Dale Hanson, MD accepts the following insurance providers:
Dr. Robin Dale Hanson, MD has an exceptional overall rating with an average of 5.0 out of 5 stars based on 8 ratings. We collect ratings and reviews of Dr. Robin Dale Hanson, MD from all over the web to help you find the right in St. Louis, MO.
These charts describe general payments received by Dr. Robin Dale Hanson, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Novartis Pharmaceuticals Corporation |
$188
ADAKVEO $25 |
PROMACTA $24 |
$139 |
|---|---|---|---|
| Shire North American Group Inc |
$97
Oncaspar $97 |
||
| Amgen Inc. |
$39
Blincyto $39 |
||
| Pfizer Inc. |
$37
OXBRYTA $37 |
||
| Emmaus Medical, Inc. |
$25
Endari $25 |
||
| Other |
$51
Voranigo $19 |
HEMLIBRA $16 |
Erwinaze $15 |
| Food and Beverage | $436 |
|---|
Dr. Robin Dale Hanson, MD has received 13 research payments totaling $284,346.
I think that one of the advantages of being a part of this children's oncology group is that were using the same treatment protocol that every other pediatric institution is using for each type of cancer, for each diagnosis. So, whether you're at St. Jude's, or at Dana-Farber, or here at Mercy Children's Hospital, the treatment protocols that were using and the way that were administering those treatments is exactly the same.